Q&A: Time to pull back the veil on pharmacy benefits middlemen
Tuesday, February 21, 2017
Posted by: Danielle Adams
Recent debates about drug pricing have tended to focus on manufacturers and patients, but Doug Collins is among the few legislators looking at the middlemen.
Click here for the full article.